Skip to main content
  • COVID-19
    • COVID-19 vaccines and cancer
      • FAQs
      • FAQs in-language
      • SerOzNET Study
    • COVID-19 information for people affected by cancer
      • Managing your cancer care in the context of COVID-19
      • Looking after your mental wellbeing
      • Canada
      • Ireland
      • UK
      • USA
    • COVID-19 information for children and young people with cancer
    • Cancer Won’t Wait
    • Cancer and COVID-19 - what it means for our Mob
      • COVID-19 vaccines: Information for Aboriginal and Torres Strait Islander people affected by cancer
      • Act early for our Mob's health
    • Guidance for health professionals
      • Diagnosis
      • Treatment
      • Surgery
      • Medical oncology
      • Radiation oncology
      • Primary care
      • Telehealth
      • Clinical trials
      • Follow-up care
      • Supportive and Palliative care
      • Cancer care for cancer patients with COVID-19
      • COVID-19 vaccines and cancer
      • Recovery
    • Research articles
      • Review articles
      • Data articles
      • Recommendations articles
      • Shared experience articles
      • COVID-19 vaccines and cancer articles
    • Cancer care in the time of COVID-19: A conceptual framework
    • Optimal cancer care during the COVID-19 pandemic: the Principles
    • The impact of COVID-19 on cancer services
    • COVID-19 Recovery: Implications for cancer care
      • Expanded use of telehealth
      • Changes to prevention and early detection
      • Virtual multidisciplinary team meetings
      • Modifications to treatment schedules
      • Hypofractionated radiotherapy
      • Oncology hospital in the home
      • Responsive patient support
      • Innovative care and hospital infrastructure models
      • Shared follow-up and survivorship care
      • Supportive and palliative care
      • Cancer research and clinical trials
      • Collaboration in the oncology sector and data sharing
      • Acknowledgements
  • About us
    • Organisational structure
    • Accountability and reporting
      • Annual reports
    • Who we work with
      • Roles & functions
      • Advisory Council
      • Advisory groups
      • Consumer engagement
      • Government cancer control organisations
    • Information publication scheme
      • Information publication scheme plan
      • Freedom of information act
        • The FOI request process
      • FOI disclosure log
    • Reconciliation action plan
    • Employment opportunities
  • News and media
    • News
    • Subscribe to our eNewsletter
  • Contact us
Cancer Australia
Choose Language
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • Home
  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives
  • Home
  • Cancer types
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children’s cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary cancer
    • Uterine sarcoma
    • Vaginal cancer
    • Vulvar cancer
  • Impacted by Cancer
    • What is cancer
    • Physical changes
    • Treatment
    • Keeping healthy
    • Emotions
    • Family and relationships
    • Living with cancer
  • Awareness
    • Your cancer risk
    • Screening
    • Interactive body map
  • Research
    • Cancer Research in Australia
    • Data and statistics
    • Australian Clinical Trials
    • Support for cancer clinical trials
    • Grants and funding
  • Resources
    • Cancer Australia Publications
    • Clinical Practice Guidelines
    • Position statements
    • Resources in other languages
    • Cancer Australia websites
    • Cancer risk online assessment tools
    • Other tools and resources
    • Podcasts
    • Cancer support organisations
    • Glossary
  • Clinicians hub
    • GP guides and resources
    • Guidelines by cancer type
    • Optimal cancer care pathways
    • Working with Aboriginal and Torres Strait Islander people
    • Multidisciplinary care
    • Psychosocial care
    • Follow-up care
    • Family cancer clinics
    • Cancer Learning
    • Consumer engagement
  • Key initiatives
    • For Aboriginal and Torres Strait Islander people
    • Australian Cancer Plan
    • Australian Brain Cancer Mission
    • Jeannie Ferris Award
    • Lung Cancer Screening
    • National Pancreatic Cancer Roadmap
    • Campaigns & events

Breast cancer

breast-mm cancer-types/breast-cancer/overview
    • Home
    • Types
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget's disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
    • Statistics
    • Risk factors
    • Symptoms
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget’s disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
    • Awareness
      • iPrevent
    • Diagnosis
      • Tests
        • Triple test
      • Stages of breast cancer
      • Receiving a diagnosis
      • Diagnosis of early breast cancer
      • Diagnosis of ductal carcinoma in situ
      • Diagnosis when breast cancer spreads
      • Questions to ask
    • Treatment
      • Treatment team
        • Members of the team
        • Talking with health professionals
        • Questions to ask
      • Deciding about treatment
        • Travelling
        • Pregnancy
        • Tips for making decisions
        • Questions to ask
        • MammaPrint ® (70 gene signature) test
      • Surgery
        • Breast-conserving surgery
        • Mastectomy
        • Surgery to the armpit (axilla)
        • Surgery for metastatic breast cancer
        • Breast reconstruction
        • Choosing a surgeon
        • Questions to ask
        • Care after surgery
      • Radiotherapy
        • Early breast cancer
        • Metastatic breast cancer
        • Questions to ask
        • Skin care
        • Travelling
      • Chemotherapy
        • How does chemotherapy work?
        • Type of chemotherapy
        • What does chemotherapy involve?
        • Side effects
        • Questions to ask
      • Hormonal therapies
        • Hormone receptors
        • Types of hormonal therapy
        • Side effects
        • Menopause and oestrogen production
        • Deciding about hormonal therapies
        • Questions to ask
      • Targeted therapies
        • HER2 receptors
        • Types of targeted therapy
        • Questions to ask
      • Complementary & alternative therapies
      • Palliative care
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget's disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
      • Follow-up
      • Advanced disease
        • When treatment stops
        • Facing the possibility of dying
        • Putting your affairs in order
        • Questions to ask
      • Recurrent and secondary cancer
    • Living with
      • Practical aspects of diagnosis
        • Costs of treatment and prostheses
        • Travel schemes
        • Questions to ask
        • Choosing a cancer treatment
      • Physical changes
        • Body image
        • Menopause
        • Fertility
        • Lymphoedema
      • Emotional changes
        • How you might feel
        • Effects on partners
        • Effects on children
        • Effects on family and friends
      • Physical changes – metastatic
        • Pain
        • Symptoms and treatment side effects
      • Emotional changes – metastatic
      • Practical aspects - metastatic
        • Work
        • Financial support
        • How to access support at home
        • How to access support outside home
        • Questions to ask
    • Life after
      • Health
        • Fatigue
        • Poor sleep
        • Lymphoedema
        • Menopause
        • Pain
        • Diet
        • Exercise
      • Feelings
      • Relationships
      • Practical issues
    • Support
    • Clinical trials
    • Health professionals
      • Menopausal symptoms
      • Screening
      • Breast cancer diagnosis
      • Early breast cancer
      • Metastatic breast cancer
      • Ductal carcinoma
      • Lobular carcinoma
      • GP guides and resources
      • Follow-up care
      • Breast cancer Qstream
    • Home
    • Types
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget's disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
    • Statistics
    • Risk factors
    • Symptoms
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget’s disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
    • Awareness
      • iPrevent
    • Diagnosis
      • Tests
        • Triple test
      • Stages of breast cancer
      • Receiving a diagnosis
      • Diagnosis of early breast cancer
      • Diagnosis of ductal carcinoma in situ
      • Diagnosis when breast cancer spreads
      • Questions to ask
    • Treatment
      • Treatment team
        • Members of the team
        • Talking with health professionals
        • Questions to ask
      • Deciding about treatment
        • Travelling
        • Pregnancy
        • Tips for making decisions
        • Questions to ask
        • MammaPrint ® (70 gene signature) test
      • Surgery
        • Breast-conserving surgery
        • Mastectomy
        • Surgery to the armpit (axilla)
        • Surgery for metastatic breast cancer
        • Breast reconstruction
        • Choosing a surgeon
        • Questions to ask
        • Care after surgery
      • Radiotherapy
        • Early breast cancer
        • Metastatic breast cancer
        • Questions to ask
        • Skin care
        • Travelling
      • Chemotherapy
        • How does chemotherapy work?
        • Type of chemotherapy
        • What does chemotherapy involve?
        • Side effects
        • Questions to ask
      • Hormonal therapies
        • Hormone receptors
        • Types of hormonal therapy
        • Side effects
        • Menopause and oestrogen production
        • Deciding about hormonal therapies
        • Questions to ask
      • Targeted therapies
        • HER2 receptors
        • Types of targeted therapy
        • Questions to ask
      • Complementary & alternative therapies
      • Palliative care
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget's disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
      • Follow-up
      • Advanced disease
        • When treatment stops
        • Facing the possibility of dying
        • Putting your affairs in order
        • Questions to ask
      • Recurrent and secondary cancer
    • Living with
      • Practical aspects of diagnosis
        • Costs of treatment and prostheses
        • Travel schemes
        • Questions to ask
        • Choosing a cancer treatment
      • Physical changes
        • Body image
        • Menopause
        • Fertility
        • Lymphoedema
      • Emotional changes
        • How you might feel
        • Effects on partners
        • Effects on children
        • Effects on family and friends
      • Physical changes – metastatic
        • Pain
        • Symptoms and treatment side effects
      • Emotional changes – metastatic
      • Practical aspects - metastatic
        • Work
        • Financial support
        • How to access support at home
        • How to access support outside home
        • Questions to ask
    • Life after
      • Health
        • Fatigue
        • Poor sleep
        • Lymphoedema
        • Menopause
        • Pain
        • Diet
        • Exercise
      • Feelings
      • Relationships
      • Practical issues
    • Support
    • Clinical trials
    • Health professionals
      • Menopausal symptoms
      • Screening
      • Breast cancer diagnosis
      • Early breast cancer
      • Metastatic breast cancer
      • Ductal carcinoma
      • Lobular carcinoma
      • GP guides and resources
      • Follow-up care
      • Breast cancer Qstream
  1. Home
  2. Treatment
  3. Chemotherapy
  4. Side effects
  • Treatment team
  • Deciding about treatment
  • Surgery
  • Radiotherapy
  • Chemotherapy
    • How does chemotherapy work?
    • Type of chemotherapy
    • What does chemotherapy involve?
    • Side effects
    • Questions to ask
  • Hormonal therapies
  • Targeted therapies
  • Complementary & alternative therapies
  • Palliative care
  • Ductal carcinoma in situ
  • Lobular carcinoma in situ
  • Early breast cancer
  • Paget's disease of the nipple
  • Inflammatory breast cancer
  • Locally advanced breast cancer
  • Metastatic breast cancer
  • Follow-up
  • Advanced disease
  • Recurrent and secondary cancer
Loading...

Side effects

  • Printer-friendly version
  • A|A

Because the drugs all work differently, they have different side effects. Chemotherapy drugs can also affect individual women in different ways. Most side effects of chemotherapy can be managed with medical care.

Some of the possible side effects of chemotherapy are listed below. It’s unlikely that a woman will have many or all of these side effects. It’s also important to remember that having chemotherapy can have great benefits.

It’s possible to have chemotherapy with very few side effects. If this happens, it doesn’t mean that the chemotherapy is not working.

Common side effects of chemotherapy include:

  • nausea and vomiting
  • fatigue (tiredness)
  • hair loss
  • diarrhoea or constipation
  • weight gain or weight loss
  • mouth ulcers and infections
  • skin or nail changes or reactions
  • menopausal symptoms (temporary or permanent)
  • depression or anxiety
  • sexual difficulties
  • nerve and muscle problems
  • swelling in the arms and legs

Less common side effects of chemotherapy include:

  • feeling ‘vague’ or ‘in a fog’

The following side effects of chemotherapy are rare but can be quite serious (medical advice should be sought if any of the following occur):

  • infection due to a low level of white blood cells
  • bleeding or bruising
  • kidney or bladder problems
  • heart problems
  • bone marrow problems
  • allergic reactions.

Nausea and vomiting

Nausea (‘feeling sick’) and vomiting are common side effects of chemotherapy. These symptoms are less common with chemotherapy programs that involve taxanes. Some women are nervous or worried before their next cycle of treatment and this can make them feel sick or vomit. This is called anticipatory vomiting.

What can help with nausea and vomiting?

Nausea and vomiting can usually be controlled using drugs called anti-emetics. Anti-emetics are usually given at the same time as chemotherapy. Effective treatments are available for anticipatory vomiting, such as relaxation training. It can be helpful to eat smaller meals more often rather than larger meals while having chemotherapy.

Nausea and vomiting can usually be controlled using drugs called anti-emetics. Anti-emetics are usually given at the same time as chemotherapy. Effective treatments are available for anticipatory vomiting, such as relaxation training. It can be helpful to eat smaller meals more often rather than larger meals while having chemotherapy.


Fatigue

Feeling tired is a common side effect of chemotherapy and can last 3–6 months after treatment is over. Fatigue can also be due to anaemia caused by chemotherapy. Blood tests are used during chemotherapy so that doctors can check the woman’s blood cell count. A red blood cell transfusion may be recommended if significant anaemia develops.

What can help with fatigue?

It can be useful to organise practical help before starting treatment, for example, help with childcare or making meals.

A normal reaction to feeling tired is to rest. However, exercising during and after treatment can help women feel less tired. It can also reduce the chance of weight gain. Exercise has also been shown to help improve sleep, body image and mood. Gentle exercise like walking is ideal. Some women find that more strenuous exercise is also helpful.


Hair loss

Not all chemotherapy drugs cause hair loss. However, the drugs most frequently used to treat early breast cancer are likely to cause hair loss. Hair loss is more common with chemotherapy programs that include anthracyclines and taxanes.

Hair loss from chemotherapy can range from mild thinning of the hair to total hair loss, including body hair. When the hair grows back it may be more curly, thicker or finer than it was before treatment. It may grow back a slightly different colour.

Although losing hair loss may not seem serious compared with coping with breast cancer, many women find it upsetting. Hair loss may affect how a woman feels about herself and her sexuality.

Coping with hair loss

Some women find it helpful to cut their hair short if they’re having chemotherapy so that it’s less upsetting if their hair does fall out. Many women choose to wear a scarf, hat or wig to cover the head while the hair grows back.

Look Good Feel Better workshops are available at locations around Australia. These are free of charge and provide tips and advice about dealing with appearance-related side effects of chemotherapy. Workshops are available in capital cities and other major centres.


Diarrhoea and constipation

Some women experience diarrhoea or constipation during chemotherapy. Constipation can be caused by chemotherapy and some anti-emetic drugs, or it can develop because women are less active or eat less during treatment.

What can help with diarrhoea and constipation?

Medication can be used to control symptoms of diarrhoea and constipation. Constipation can be treated by drinking more fluids, eating more fruit and vegetables, and using laxatives. Exercise can also be helpful in reducing constipation.


Weight gain or weight loss

Some women lose their appetite during chemotherapy and lose weight. Other women find that they put on weight during treatment.

What can help with weight gain/loss?

Eating small meals and snacks as often possible throughout the day can help prevent weight loss during treatment. Doing gentle exercise can help prevent weight gain during chemotherapy.


Mouth ulcers and infections

Some women receiving chemotherapy get mouth ulcers. Mouth ulcers usually occur about 5–10 days after starting chemotherapy and clear up within 1–2 weeks. Sometimes chemotherapy can cause other mouth infections in mouth, such as thrush or cold sores.

What can help with mouth ulcers and infections?

It’s important to take extra care of the mouth during chemotherapy.

Things that can help if mouth ulcers develop include:

  • brush the teeth and gums with a very soft brush after every meal to prevent infection
  • use an analgesic gel from the chemist or sodium bicarbonate mouthwash to help relieve discomfort
  • pain relief such as paracetamol may be helpful.

Some mouthwashes can make ulcers worse – advice should be sought from a health professional before using a mouth wash. Treatments are available from a doctor or pharmacist for mouth infections such as thrush.


Skin and nail problems

Some women have minor skin or nail problems while they are having chemotherapy. These include redness, itching, peeling, dryness or acne. Some women’s nails become darker, brittle or cracked. Some chemotherapy drugs can make the skin more sensitive to the sun.

Most skin and nail problems are not serious. However, a sudden rash, sudden or severe itching, or breathing difficulties could be symptoms of a severe allergic reaction that requires treatment. Medical assistance should be sought immediately from a doctor or hospital emergency department.

Hand–foot syndrome can be a side effect of chemotherapy that includes capecitabine or liposomal doxorubicin (Caelyx®) (used to treat metastatic breast cancer). The skin of the hands or feet can become red, swollen, cracked or painful. For many women, symptoms are mild and do not interfere with daily activities. However, for some women, the symptoms can be very painful and can make it difficult to walk or use the hands.

What can help with skin and nail problems?

It’s recommended that women having drugs that affect the skin and nails avoid being in the sun for long periods, and use sunscreen when outdoors. Health professionals can provide advice about managing skin and nail problems caused by chemotherapy and about moisturisers that can be used to manage hand-foot syndrome.


Menopausal symptoms and permanent menopause

About two-thirds of women who are younger than 50 when their breast cancer is diagnosed will go through menopause because of their treatment. Other women may experience temporary menopausal symptoms. The closer a woman is to the age of natural menopause, the more likely it is that menopause will be permanent. Find out more about menopause and breast cancer.

If menopause is permanent, it’s not possible to have children naturally after treatment. Women who have not yet reached menopause and hope to have children in the future should talk to a fertility specialist before making treatment decisions and starting treatment.

Find out more about:

  • Fertility and breast cancer
  • Breast cancer and menopause

Depression and anxiety

Some women feel depressed, sad or teary before, during and after chemotherapy. Others feel anxious, worried, nervous or upset. Some feelings of sadness, depression and anxiety are normal. 

What can help with depression and anxiety?

Treatments are available for women experiencing feelings or emotions that are interfering with things at home, or affecting relationships.

Find out more about:

  • Managing feelings during and after treatment

Sexual difficulties

Many women have some sexual difficulties during chemotherapy treatment. This can be because of feeling unwell or because of the effects of treatment on the body. Some women experience these feelings for a while after treatment is over.

Find out more about:

  • Sexuality and breast cancer

Nerve and muscle problems

Some chemotherapy drugs can cause nerve and muscle problems during treatment. Severe problems are uncommon.  More common symptoms include tingling, burning or numbness in the hands or feet. Some women have problems with balance or have weak or sore muscles for a few days after chemotherapy. These symptoms are more common with taxane drugs.

Treatment can be adjusted for women experiencing nerve or muscle problems.


Swelling in the arms and legs

Swelling or fluid retention may occur, particularly in the arms and/or legs. Swelling is most common in the feet and ankles due to the effects of gravity. This side effect is most common with the use of some taxane chemotherapy drugs.

Arm and leg swelling caused by chemotherapy is not the same as lymphoedema and rarely requires any specific treatment. However, treatment may be prescribed if the swelling is severe.

The risk of arm or leg swelling can be reduced by giving another medication before chemotherapy. Symptoms will slowly improve once treatment is over.


Feeling vague or ‘in a fog’

Some women feel ‘vague’ or mildly confused or have memory problems while having chemotherapy. This is sometimes called ‘chemo brain’ or ‘chemo fog’. Symptoms can last for some months after treatment is over.

The causes of these feelings are being studied.


Infection

Chemotherapy drugs reduce the number of white blood cells produced by the body. The white blood cell count will be checked regularly during chemotherapy. If the white blood cell count drops, this will usually happen 1–2 weeks after treatment.

Women with a low white blood cell count may be at increased risk of developing an infection. The risk of infection is highest for people who have drugs called taxanes at the same time as anthracyclines. A drug called a growth factor (G-CSF) may be given after each chemotherapy treatment to lower the risk of infection.

Signs of a severe, life-threatening infection may include:

  • fever (a temperature higher than 38ºC)
  • chills
  • severe sweats.

If these symptoms develop, immediate medical advice should be sought as treatment with strong antibiotics may be required.

Other symptoms of infection include:

  • loose bowels
  • a burning sensation during urination
  • severe cough or sore throat
  • unusual vaginal discharge or itching
  • redness, swelling or tenderness around a wound, sore, pimple, boil, or the site where the chemotherapy drip was inserted.

Infections during chemotherapy can be treated effectively with antibiotics.


Bleeding or bruising (rare)

In rare cases, chemotherapy can make a woman bleed or bruise more easily. This is because chemotherapy can affect cells in the blood called platelets. The platelet count will be checked during chemotherapy.

If chemotherapy affects the platelets, this will usually happen 1–2 weeks after treatment.

Symptoms to look out for include:

  • easy bruising
  • bleeding from gums or nose
  • reddish urine
  • black or bloody bowel motions (stools).

These symptoms should be reported to a health professional as soon as possible.

Unusual bruising or bleeding can be treated by a platelet transfusion.


Kidney and bladder problems (rare)

Some chemotherapy drugs can irritate the bladder or cause damage to the kidneys. In very rare cases, this damage can be permanent. If kidney or bladder problems do develop, they will usually happen a few days or more after chemotherapy treatment.

Symptoms to look out for include:

  • pain or burning during urination
  • frequent urination
  • feeling the need to urinate right away
  • reddish or bloody urine
  • fever or chills.

These symptoms should be reported to a health professional as soon as possible.

With some chemotherapy drugs, it’s normal to have reddish urine for 24 hours after treatment. Reddish urine caused by an infection in the bladder or kidneys usually develops a few days or more after treatment.

Drinking plenty of fluid can help prevent kidney and bladder problems.


Other rare/uncommon side effects of chemotherapy

Other rare side effects of chemotherapy include:

  • heart problems (cardiac toxicity) – with anthracyclines
  • problems with bone marrow – most commonly with anthracyclines
  • allergic reactions – with taxanes.

If these side effects develop during treatment the chemotherapy drugs will be changed, or the dose decreased. Drugs can be given before chemotherapy to lower the chance of an allergic reaction.

Find out more

  • Guidance for the management of early breast cancer
  • Last Updated
  • Relevant Links
updated: 20 October 2020 - 3:32pm
Australian Cancer Trials

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2023 - Cancer Australia